Ad
related to: AbbVie- Read AbbVie Stories
Read Stories About Our Science,
People, and More Today.
- AbbVie News Center
See Our Achievements, Growth Story,
and More Today.
- Read AbbVie Stories
Search results
Novo Nordisk, Lilly must cut US prices of weight-loss drugs, Biden says
Reuters via Yahoo Canada News· 3 days ago(Reuters) -U.S. President Joe Biden and Senator Bernie Sanders called on Novo Nordisk and Eli Lilly...
Euronext Paris Growth Leaders With High Insider Ownership And Up To 101% Earnings Growth
Simply Wall St. via Yahoo Finance Canada· 7 days agoAmidst a backdrop of broad gains across European markets, with France's CAC 40 Index notably...
News By Company | Zymeworks Inc. News on T-Net
T-Net British Columbia· 2 days agoZymeworks
Euronext Paris Growth Leaders With High Insider Stakes July 2024
Simply Wall St. via Yahoo Finance Canada· 4 days agoAmid a backdrop of heightened political uncertainty and fluctuating market indices in France,...
Euronext Paris Showcases Three Growth Companies With High Insider Ownership
Simply Wall St. via Yahoo Finance Canada· 4 days agoAs the French market navigates through heightened political uncertainty with upcoming elections,...
MedinCell And Two More Euronext Paris Growth Stocks With High Insider Ownership
Simply Wall St. via Yahoo Finance Canada· 2 days agoAs the French market navigates through a period of political uncertainty with upcoming elections,...
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
Zacks via Yahoo Finance Canada· 7 days agoLuckily, most ETFs are very transparent products that disclose their holdings on a daily basis. For...
Top Insider-Owned Growth Companies On Euronext Paris July 2024
Simply Wall St. via Yahoo Finance Canada· 3 days agoAmid a backdrop of heightened political uncertainty and fluctuating market indices, France's...
NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
Digital Journal· 6 days agoNurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, is pleased to announce a pre-clinical study to explore ...
FDA Approves Skyrizi for Ulcerative Colitis
AOL· 7 days agoThe FDA has approved Skyrizi, a drug already used to address psoriasis and Crohn’s disease, for the treatment of ulcerative colitis. Ulcerative colitis is a chronic inflammatory bowel disease ...
Ad
related to: AbbVie